Association of dNLR Score with Outcomes in Patients with Advanced NSCLC Under Immunotherapy Alone plus /- Chemotherapy Upfront

被引：0
|
作者：
Gorria, T. [1 ]
Torres-Jimenez, J. [1 ,2 ]
Auclin, E. [3 ]
Castro, N. [4 ]
Albarran-Artahona, V. [1 ]
Ruffinelli, J. C. [5 ]
Pinato, D. [6 ]
Routy, B. [7 ]
Nana, F. Aboubakar [8 ]
Reyes, R. [1 ]
Vinolas, N. [1 ,9 ]
Teixido, C. [1 ,9 ]
Blanc-Durand, F. [10 ]
Planchard, D. [10 ]
Lopes, G. [11 ]
Nadal, E. [5 ]
Arasanz, H. [4 ,12 ]
Pascal, M. [1 ,9 ]
Prat, A. [1 ,9 ]
Reguart, N. [1 ,9 ]
Besse, B. [10 ]
Mezquita, L. [1 ,9 ]
机构：
[1] Hosp Clin Barcelona, Barcelona, Spain
[2] Hosp Univ Ramon & Cajal, Barcelona, Spain
[3] Hop European George Pompidou, Paris, France
[4] Hosp Univ Navarra, Pamplona, Spain
[5] Catalan Inst Oncol, Barcelona, Spain
[6] Hammersmith Hosp, Imperial Coll London, London, England
[7] Ctr Hosp Univ Montreal, Montreal, PQ, Canada
[8] Catholic Univ Louvain, Inst Rech Expt & Clin IREC, Pole Pneumol ORL & Dermatol PNEU, Brussels, Belgium
[9] IDIBAPS, Translat Genom & Targeted Therapeut Solid Tumor, August Pi Sunyer Biomed Res Inst, Barcelona, Spain
[10] Gustave Roussy, Villejuif, France
[11] Univ Miami, Sylvester Comprehens Canc Ctr, Miami, FL USA
[12] IdiSNA, Oncoimmunol Grp, Navarrabiomed, Pamplona, Spain
来源：
JOURNAL OF THORACIC ONCOLOGY | 2022年 / 17卷 / 09期
关键词：
dNLR-score; Immunotherapy; Prognostic Factor;
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
EP08.01-09
引用
收藏
页码：S386 / S386
页数：1
相关论文
共 50 条
  • [1] Association of Gender and Outcomes in Patients With Advanced NSCLC Treated With Immunotherapy Alone or in Combination With Chemotherapy Upfront
    Jimenez, J. Torres
    Gorria, T.
    Auclin, E.
    Castro, N.
    Albarran-Artahona, V.
    Ruffinelli, J. C.
    Pinato, D.
    Routy, B.
    Nana, F. Aboubakar
    Reyes, R.
    Vinolas, N.
    Blanc-Durand, F.
    Lopes, G.
    Nadal, E.
    Arasanz, H.
    Pascal, M.
    Teixido, C.
    Besse, B.
    Reguart, N.
    Mezquita, L.
    Jimenez, J. Torres
    JOURNAL OF THORACIC ONCOLOGY, 2022, 17 (09) : S385 - S386
  • [2] Lung Immune Prognostic Index Predicts Outcomes from Upfront Chemotherapy plus Immunotherapy plus /Antiangiogenic in Advanced NSCLC
    Dugage, M. Roulleaux
    Gorria, T.
    Rochand, A.
    Garcin, L. -M.
    Oudard, S.
    Albarran-Artahona, V.
    Laguna, J. C.
    Nalda, I.
    Munoz-Carrillo, F. J.
    Aguilar, L.
    Arcocha, A.
    Lupinacci, L.
    Teixido, C.
    Besse, B.
    Mezquita, L.
    Auclin, E.
    JOURNAL OF THORACIC ONCOLOGY, 2023, 18 (11) : S80 - S80
  • [3] Early Change of dNLR Is Correlated with Outcomes in Advanced NSCLC Patients Treated with Immunotherapy
    Mezquita, L.
    Preeshagul, I.
    Auclin, E.
    Saravia, D.
    Hendriks, L.
    Rizvi, H.
    Planchard, D.
    Park, W.
    Nadal, E.
    Ruffinelli, J. C.
    Ponce, S.
    Audigier-Valette, C.
    Carnio, S.
    Novello, S.
    Zalcman, G.
    Majem, M.
    Mariniello, A.
    Dingemans, A. M.
    Lopes, G.
    Rossoni, C.
    Pignon, J.
    Chaput, N.
    Hellmann, M.
    Arbour, K.
    Besse, B.
    JOURNAL OF THORACIC ONCOLOGY, 2019, 14 (10) : S273 - S273
  • [4] Predicting immunotherapy outcomes under therapy in patients with advanced NSCLC using dNLR and its early dynamics
    Mezquita, Laura
    Preeshagul, Isabel
    Auclin, Edouard
    Saravia, Diana
    Hendriks, Lizza
    Rizvi, Hira
    Park, Wungki
    Nadal, Ernest
    Martin-Romano, Patricia
    Ruffinelli, Jose C.
    Ponce, Santiago
    Audigier-Valette, Clarisse
    Carnio, Simona
    Blanc-Durand, Felix
    Bironzo, Paolo
    Tabbo, Fabrizio
    Reale, Maria Lucia
    Novello, Silvia
    Hellmann, Matthew D.
    Sawan, Peter
    Girshman, Jeffrey
    Plodkowski, Andrew J.
    Zalcman, Gerard
    Majem, Margarita
    Charrier, Melinda
    Naigeon, Marie
    Rossoni, Caroline
    Mariniello, AnnaPaola
    Paz-Ares, Luis
    Dingemans, Anne Marie
    Planchard, David
    Cozic, Nathalie
    Cassard, Lydie
    Lopes, Gilberto
    Chaput, Nathalie
    Arbour, Kathryn
    Besse, Benjamin
    EUROPEAN JOURNAL OF CANCER, 2021, 151 : 211 - 220
  • [5] Association of the Metabolic Score Using Baseline FDG-PET/CT and dNLR with Immunotherapy Outcomes in Advanced NSCLC Patients Treated with First-Line Pembrolizumab
    Seban, Romain-David
    Assie, Jean-Baptiste
    Giroux-Leprieur, Etienne
    Massiani, Marie-Ange
    Soussan, Michael
    Bonardel, Gerald
    Chouaid, Christos
    Playe, Margot
    Goldfarb, Lucas
    Duchemann, Boris
    Mezquita, Laura
    Girard, Nicolas
    Champion, Laurence
    CANCERS, 2020, 12 (08) : 1 - 14
  • [6] Immunotherapy plus chemotherapy showed superior clinical benefit to chemotherapy alone in advanced NSCLC patients after progression on osimertinib
    Long, Yaping
    Xiong, Qi
    Song, Qi
    Li, Yao
    Li, Xiaoyan
    Qin, Boyu
    Huang, Ziwei
    Hu, Yi
    Yang, Bo
    THORACIC CANCER, 2022, 13 (03) : 394 - 403
  • [7] Clinical Value of Patras Immunotherapy Score (PIOS) Formula in Patients With Advanced NSCLC Treated With Immunotherapy/Chemotherapy
    Dimitrakopoulos, F-I.
    Christopoulos, P.
    Elshiaty, M.
    Daniello, L.
    Pyrousis, I.
    Kottorou, A.
    Makatsoris, T.
    Kalofonos, H.
    Koutras, A.
    JOURNAL OF THORACIC ONCOLOGY, 2022, 17 (09) : S374 - S375
  • [8] Association of Sarcopenia with Survival in Advanced NSCLC Patients Receiving Concurrent Immunotherapy and Chemotherapy
    Bolte, F. J.
    McTavish, S.
    Wakefield, N.
    Shantzer, L.
    Hubbard, C.
    Krishnaraj, A.
    Novicoff, W.
    Hall, R.
    JOURNAL OF THORACIC ONCOLOGY, 2022, 17 (09) : S353 - S353
  • [9] Association of sarcopenia with survival in advanced NSCLC patients receiving concurrent immunotherapy and chemotherapy
    Bolte, Fabian J. J.
    McTavish, Sloane
    Wakefield, Nathan
    Shantzer, Lindsey
    Hubbard, Caroline
    Krishnaraj, Arun
    Novicoff, Wendy
    Gentzler, Ryan D. D.
    Hall, Richard D. D.
    FRONTIERS IN ONCOLOGY, 2022, 12
  • [10] Cetuximab plus chemotherapy in patients with advanced NSCLC
    Rasul, Kakil Ibrahim
    Kerr, David J.
    NATURE REVIEWS CLINICAL ONCOLOGY, 2009, 6 (09) : 499 - 500
12345